Toxoplasma retinochoroiditis, a comparison of treatment between spiramycin and pyrimethamine/sulfadiazine;Toxoplasmose-retinochorioiditis, ein therapievergleich zwischen spiramycin und pyrimethamin/sulfadiazin

Klinische Monatsblatter fur Augenheilkunde

Volumn 212, Issue 2, 1998, Pages 84-87

  Hacker, Markus ^a   Richter, Roland ^a   Gümbel, Hermann ^a   Richter, Traute ^a   Ohrloff, Christian ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Spiramycin; Toxoplasma retinochoroiditis

Indexed keywords

PYRIMETHAMINE; PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN; SULFADIAZINE;

ALLERGIC REACTION; BREAST FEEDING; CHORIORETINITIS; CLINICAL ARTICLE; DRUG MIXTURE; FEMALE; HUMAN; MALE; PREGNANCY; RASH; REVIEW; TOXOPLASMOSIS; TREATMENT CONTRAINDICATION;

EID: 0031942178     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1034838     Document Type: Review

References (29)

1. Acers TE. Toxoplasmic retinochorioiditis: a double blind therapeutic study. Arch Ophthalmol 1964;71:58-68
2. Brooks RG, McDabe RE, Remington JS. Role of serology in the diagnosis of toxoplasmic lymphadenopathy. Rev Inf Dis 1987;9:1055-1062
3. Chodos JB, Habegger-Chodos HE. The treatment of ocular toxoplasmosis with spiramycin. Arch Ophthalmol 1961;65:401-408
4. Couvrent J, Desmonts G, Tournuer G, Szusterkac M. Etude d'une série homogène de 210 cases de toxoplasmose congénitale chez des nourrissons age de 0-11 mots et dépistes de fecon prospective. Ann Pédiatr Paris 1984;31:815-822
5. Dube MP, Sattler FR. Prevention and treatment of opportunistic infections. Aids 1993;6:230-240
6. Enders G. Toxoplasmose in der Schwangerschaft. In: Shah PM, Stille W; Infektionen durch Toxoplasma gondii. Gräfelfing. Socio medico Verlag 1992:33-52
7. Engstrom RE, Holland GN, Nussenblatt RB, Douglas AJ. Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 1991;111:601-610
8. Eyles DE, Coleman N. Synergistic effect of sulfadiazine and daraprim against experimental toxoplasmosis in the mouse. Antibiot Chemother 1953;3:483-192
9. Eyles DE, Coleman N. An evaluation of th curative effects of pyrimethamin and sulfadiazine, alone and in combination, on experimental mouse toxoplasmosis. Antibiot Chemother 1955;5:579-535
10. Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis. Am J Ophthalmol 1987;103: 131-142
11. Katlama C, Dickinson GM. Update on opportunistic Infections. Aids 1993;7, Suppl. 1:185-192
12. Luft BJ, Remington JS. Toxoplasmic encephalitis in Aids. Clin Infect Dis 1989;15:211-220
13. Luft BJ, Remington JS. Toxoplasmosis. In: Hoeprich MC. Jordan: Infectious diseases. Philadelphia. JB Lippincott Company 1989;1199-1220
14. Mc Cable RE, Oster S. Current recommendations and future prospects in the treatment of toxoplasmosis. Drugs 1989;38:973-978
15. McCable RE, Remington JS. Toxoplasma gondii. In: Mandell GL, Douglas RG, Bennet JE: Principles and practice of infectious diseases, New York, Churchill Livingstone Inc. 1990:2090-2105
16. Mimoun G, Binaghi M, Albengres E, Chaine G, Koso M, Saiag P, Coscas G, Tillement JP. Syndrome de Stevens-Johnson et choroidite toxoplasmique. Bull Soc Ophtalmol Fr 1988;88:961-965
17. Ockert G. Epidemiologie der Tuxoplasmose-Infektion. In: Pohle HD, Remington JS; Toxoplasmose - Erreger und Krankheit. Gräfelfing. Socio medico Verlag 1994:30-42
18. Pavesto CEN, Belfort R, Freuas D de, Toledo de Abreu M. Toxoplasmose ocular. Enigma a espera de estudos clinicos adequados. Arq Bras Oftalmol 1987;50 2:91-93
19. Perkins ES, Folk J. Uveitis in London and Iowa. Ophthalmologica 1984;189:36-40
20. Perkins ES, Smith CH, Schofield PB. Treatment of uveitis with pyrimethamin (Daraprim). Br J Ophthalmol 1956;40:577-586
21. Remington JS. Vorschläge für eine rationelle Therapie der Toxoplasmose. In: Shaw PM. Stille W; Infektionen durch Toxoplasma gondii. Gräfelfing, Sociomedico Verlag 1992:95-102
22. Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO: Infectious diseases of the fetus and newborn infant. Philadelphia, WB Saunders Company 1991:89-117
23. Rothova A, Meenken C., Buttenhuis HJ, Brinkman CJ, Baarsma GS, Boen-Tan TN et al. Therapy for ocular toxoplasmosis. Am J Ophthalmol 1993;115:517-523
24. Rothova A, Buttenhuis HJ, Meenken C, Baarsma GS, Boen-Tan TN, de Jong P et al. Therapy of ocular toxoplasmosis. Int Ophthalmol 1989; 13:415-422
25. Schlacgel TF. Differential diagnosis of uveitis. Ophthalmol Digest 1973; 35:34-46
26. Schoondermark-Van de Ven E, Galama J, Camps W, Meuwessen J, Melchers W. Pharmacokinetics and effectivity of spiramycin treatment of congenital Toxoplasma gondii infection in a rhesus monkey model. 18th International congress of Chemotherapy, Stockholm 1993; Abstract 202
27. Verin P, Comte P, Haroche S, Capsec F. Conduite therapeutique et surveillance del la toxoplasmose oculaire. Bull Mem Soc Fr Ophtalmol 1986;97:28-32
28. Werner H Gegen ärztliche Resignation im Umgang mit der Uveitis. Klin Monatsbl Augenheilkd 1986;188:376-381
29. Woods AC. Modern concepts of the etiology of uveitis. Am J Ophthalmol 1966;50:1170-1178